Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03020914
Other study ID # 2016-0648
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 2017
Est. completion date May 2019

Study information

Verified date May 2022
Source Hospital for Special Surgery, New York
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Patients will be randomly assigned to either one of two groups: 1. Standard of care sedation 2. Audiovisual distraction during surgery and in the recovery room using video goggles and headphones; patients can choose a movie from a preexisting library Monitoring and anesthesia regimen will be standardized


Description:

Before consent patients will be thoroughly informed about possible risks or benefits and about their possibilities to end the study at any time point or to ask for additional sedation if they feel uncomfortable or anxious. After they consent, they will be randomly assigned to either receive standard sedation (Group 1) or audiovisual distraction (Group 2). Each group will consist of 30 patients. The randomization schedule will be created by a member of the Healthcare Research Institute using SAS software, who is not otherwise involved in the trial. 1. Standard of care sedation with an initial dose of midazolam in preparation for the administration of the neuraxial anesthesia; propofol infusion titrated to effect. 2. Audiovisual distraction during surgery and in the recovery room using video goggles and headphones; patients can choose a movie from a preexisting library; with an initial dose of midazolam in preparation for the administration of the neuraxial anesthesia, additional sedation with midazolam in 1 mg increments if requested by the patient or deemed necessary by the anesthesia provider. The intraoperative anesthesia regimen will be standardized: - All patients will be monitored according to the American Society of Anesthesiologists standard, receive either a radial arterial line or non-invasive blood pressure measurement according to the preferences of the anesthesia provider and O2 via nasal cannula or face mask in the operation room and the recovery room. - ondansetron,decadron and ketorolac may be administered as per clinical judgment of the attending anesthesiologist. - Patients in both groups will receive neuraxial anesthesia. The attending anesthesiologist is free to add an ultrasound guided peripheral nerve block: - Neuraxial anesthesia (combined spinal-epidural, epidural or spinal) as preferred by the attending anesthesiologist. Decadron may be used as in addition to the local anesthetic if the anesthesia provider wishes to do so. - If a peripheral nerve block is performed the appropriate amount of bupivacaine will be administered under ultrasound-guidance as a single shot. - In case an epidural catheter was placed patients will receive a patient controlled epidural analgesia immediately after arrival at the recovery room for postoperative pain management. - Opioids and other medications with sedative or respiratory depressant side effects that are not specifically mentioned above should be omitted (if possible without harm for the patient) Patients in the audiovisual distraction group will choose a movie, start watching it in the holding area and continue watching it in the operation room as well as the first 30 min in the recovery room. Audiovisual equipment will be removed for transfers or at patient request.


Recruitment information / eligibility

Status Completed
Enrollment 19
Est. completion date May 2019
Est. primary completion date May 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patients with known OSA (preexisting diagnosis of obstructive sleep apnea (OSA) or patients with a STOP BANG Score of 5 or above) undergoing primary total knee arthroplasty under neuraxial anesthesia Exclusion Criteria: - Contraindications to neuraxial anesthesia or allergy to study medication - Patients with audiovisual impairments prohibiting them from proper use of the study device: - Patients who are blind - Patients with hearing aids - Age <18 years - Patients with inability to communicate in English or understand the study requirements - Patients with prior history of claustrophobia - Patients with prior history of epilepsy or seizure disorder - Patients undergoing a revision

Study Design


Intervention

Device:
Audiovisual Distraction
watching a movie using video glasses and headphones

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Hospital for Special Surgery, New York

Outcome

Type Measure Description Time frame Safety issue
Primary Desaturations number of desaturation events (SpO2< 90% for = 10 sec) measured during this time frame start of anesthesia until 30 minutes after recovery room admission (ca. 3 hours)
Secondary Airway Interventions each airway intervention (defined as one of the following: jaw thrust, oropharyngeal airway, nasopharyngeal airway, mask ventilation, larynx mask or intubation) that is implemented during this time frame will be observed and documented by research staff, if it occurs. start of anesthesia until 30 minutes after recovery room admission (ca. 3 hours)
Secondary Additional Sedation Patient request for additional sedation intraoperative
Secondary Patient Satisfaction Patient satisfaction at recovery room discharge as measured by the Heidelberg perianesthetic questionnaire, which assesses patients' peri-anaesthetic satisfaction on a four-point Likert scale ranging from 0 (unimportant to me) to 3 (very important to me). Scores for each question are summed for a final score, with higher total score signifying higher satisfaction and lower total score signifying lower satisfaction. The score scale has a minimum value of 0 and a maximum value of 114 (based off 3 as the highest response score for 38 individual questions). 10 minutes before recovery room discharge
Secondary Alertness Levels Alertness levels measured using the Modified Observer's Assessment of Alertness/Sedation Scale (MOAA/S), which rates alertness on a scale of 0-5, with higher ratings representing increased alertness (e.g. '5 - Responds readily to name spoken in normal tone'). Results reflect a median score of ratings collected at 4 time points. 4 times: preoperative, intraoperative, at time of recovery room admission, 10 minutes before recovery room discharge
See also
  Status Clinical Trial Phase
Not yet recruiting NCT04939168 - Measuring Atomoxetine and Aroxybutynin In Patients With OSA Phase 2
Completed NCT02908529 - Atomoxetine and Oxybutynin in Obstructive Sleep Apnea Phase 1/Phase 2
Completed NCT03415633 - Validity of a Home Respiratory Polygraphy for the Diagnosis of Obstructive Sleep Apnea N/A
Completed NCT03426631 - DAW1033B2 in Obstructive Sleep Apnea Phase 1/Phase 2
Completed NCT04206449 - Sleep Thermography for Diagnosis of Obstructive Sleep Apnea (TERMOAPNEA) N/A
Active, not recruiting NCT03018912 - Validating the Use of a Subjectively Reported Sleep Vital Sign N/A
Completed NCT02549508 - Comparison Study Using APAP With and Without SensAwake in Patients With OSA and PTSD N/A
Completed NCT01249924 - The Effectiveness of Perioperative CPAP to Reduce Obstructive Sleep Apnea Related Adverse Events N/A
Completed NCT00773721 - Foam Mask - Assessment of Bioburden in a New Mask Seal Material N/A
Completed NCT02314858 - Tailored Treatment to Enhance Risk Perception in Sleep Apnea N/A
Completed NCT01476917 - The ATLAST Long-Term Study Phase 2/Phase 3
Terminated NCT00730041 - Palatal Implants in Combination With Continuous Positive Airway Pressure to Treat Obstructive Sleep Apnea Phase 4
Completed NCT00850434 - Improved Automatic CPAP Algorithm to Treat Obstructive Sleep Apnea (OSA) N/A
Enrolling by invitation NCT04538755 - DAW2020 on OSA Endotypic Traits Phase 1/Phase 2
Completed NCT02501304 - Feasibility Study of the ReVENT Sleep Apnea System N/A
Withdrawn NCT02805777 - Vent Flow Study of Prototype Nasal CPAP Mask N/A
Completed NCT02097212 - Correlation Between Trachebroncho Malacia/Hyperdynamic Airway Collapse And Obstructive Sleep Apnea N/A
Active, not recruiting NCT02295306 - Overnight Polysomnography and Respiratory Volume Monitor
Terminated NCT01877928 - Post-extubation Boussignac CPAP System in Adults With Moderate to Severe Obstructive Sleep Apnea N/A
Completed NCT01939938 - Pilot Study of the Comparison of the Upper Airway Dynamics of Oronasal vs Nasal Masks With PAP Treatment N/A